Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The American Journal of Managed Care|March 2, 2017
Treating Medicaid patients with hepatitis C: clinical and economic impactZobair Younossi, Stuart C Gordon, Aijaz Ahmed, et al.
The Journal of Biological Chemistry|November 24, 2011
p53-Dependent induction of PVT1 and miR-1204Anthony M Barsotti, Rachel Beckerman, Oleg Laptenko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
In an era of highly effective treatment, hepatitis C screening of the United States general population should be consideredZobair Younossi, Deidre Blissett, Rob Blissett, et al.
Advances in Therapy|June 5, 2023
A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular AtrophyTammy Jiang, Bora Youn, Angela D Paradis, et al.
Pediatric Blood & Cancer|May 18, 2024
A systematic literature review of clinical evidence and treatment burden in newly diagnosed high-risk pediatric patients with classical Hodgkin lymphomaJamie E Flerlage, Christine Waters-Banker, Michelle Fanale, et al.
Genes & Development|June 3, 2009
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpointRachel Beckerman, Aaron J Donner, Melissa Mattia, et al.
Journal of Clinical and Translational Hepatology|May 17, 2017
Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United StatesChanna R Jayasekera, Rachel Beckerman, Nathaniel Smith, et al.
Hepatology (Baltimore, Md.)|August 21, 2016
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and EuropeZobair M Younossi, Deirdre Blissett, Robert Blissett, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United StatesAijaz Ahmed, Stevan A Gonzalez, George Cholankeril, et al.
Scientific Reports|June 10, 2022
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysisRachel Beckerman, Andrea Gori, Sushanth Jeyakumar, et al.
Pageof 3